Jiichiro Sasaki

1.7k total citations
99 papers, 1.2k citations indexed

About

Jiichiro Sasaki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jiichiro Sasaki has authored 99 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Oncology, 67 papers in Pulmonary and Respiratory Medicine and 22 papers in Molecular Biology. Recurrent topics in Jiichiro Sasaki's work include Lung Cancer Treatments and Mutations (53 papers), Lung Cancer Research Studies (41 papers) and Colorectal Cancer Treatments and Studies (19 papers). Jiichiro Sasaki is often cited by papers focused on Lung Cancer Treatments and Mutations (53 papers), Lung Cancer Research Studies (41 papers) and Colorectal Cancer Treatments and Studies (19 papers). Jiichiro Sasaki collaborates with scholars based in Japan, United States and United Kingdom. Jiichiro Sasaki's co-authors include Satoshi Igawa, Tomoya Fukui, Noriyuki Masuda, Sakiko Otani, Masato Katagiri, Katsuhiko Naoki, Hisashi Mitsufuji, Masashi Kasajima, Yasuhiro Hiyoshi and Masaru Kubota and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Jiichiro Sasaki

91 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiichiro Sasaki Japan 18 775 681 308 150 139 99 1.2k
Koichi Kurishima Japan 19 550 0.7× 889 1.3× 313 1.0× 138 0.9× 206 1.5× 92 1.4k
Fumihiko Hirai Japan 26 1.1k 1.4× 979 1.4× 439 1.4× 181 1.2× 211 1.5× 103 1.8k
Michela Roberto Italy 19 598 0.8× 343 0.5× 294 1.0× 166 1.1× 68 0.5× 75 1.1k
Fumiyoshi Ohyanagi Japan 20 561 0.7× 673 1.0× 263 0.9× 199 1.3× 87 0.6× 68 1.1k
Sarita Dubey United States 22 692 0.9× 792 1.2× 489 1.6× 181 1.2× 52 0.4× 36 1.4k
Kazuhiko Shibata Japan 15 916 1.2× 741 1.1× 226 0.7× 215 1.4× 51 0.4× 67 1.2k
Zhihuang Hu China 19 1.0k 1.3× 601 0.9× 514 1.7× 387 2.6× 140 1.0× 53 1.6k
Yuichiro Takeda Japan 20 780 1.0× 629 0.9× 387 1.3× 118 0.8× 152 1.1× 123 1.6k
Angelica Petrillo Italy 19 551 0.7× 350 0.5× 233 0.8× 165 1.1× 130 0.9× 68 1.1k
Motoharu Hamatake Japan 17 590 0.8× 407 0.6× 238 0.8× 153 1.0× 121 0.9× 61 1.0k

Countries citing papers authored by Jiichiro Sasaki

Since Specialization
Citations

This map shows the geographic impact of Jiichiro Sasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiichiro Sasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiichiro Sasaki more than expected).

Fields of papers citing papers by Jiichiro Sasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiichiro Sasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiichiro Sasaki. The network helps show where Jiichiro Sasaki may publish in the future.

Co-authorship network of co-authors of Jiichiro Sasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Jiichiro Sasaki. A scholar is included among the top collaborators of Jiichiro Sasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiichiro Sasaki. Jiichiro Sasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shibahara, Ichiyo, Madoka Inukai, Hiroyuki Koizumi, et al.. (2021). A Case of Synchronous Occurrence of Intracranial Germinoma and Systemic Sarcoidosis. NMC Case Report Journal. 8(1). 645–650. 1 indexed citations
2.
Igawa, Satoshi, Masanori Yokoba, Akira Takakura, et al.. (2021). Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease. Investigational New Drugs. 40(1). 182–189. 2 indexed citations
3.
Igawa, Satoshi, Tomoya Fukui, Jiichiro Sasaki, et al.. (2020). Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors. Investigational New Drugs. 38(3). 885–893. 14 indexed citations
4.
Igawa, Satoshi, Takaaki Ono, Tetsuya Ozawa, et al.. (2019). EP1.01-68 Impact of EGFR Genotype on the Efficacy of Osimertinib in Patients with Non-Small Cell Lung Cancer: A Prospective Observational Study. Journal of Thoracic Oncology. 14(10). S938–S938. 1 indexed citations
5.
6.
Nakahara, Yoshiro, Tomoya Fukui, Masayuki Shirasawa, et al.. (2018). Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung Adenocarcinoma. Internal Medicine. 57(21). 3149–3152. 1 indexed citations
7.
Igawa, Satoshi, Masayuki Shirasawa, Hideyuki Sone, et al.. (2018). Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive‐disease small cell lung cancer in the elderly and patients with poor performance status. Thoracic Cancer. 9(8). 967–973. 8 indexed citations
8.
Igawa, Satoshi, Masaaki Ichinoe, Sakiko Otani, et al.. (2017). Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations. Oncology Research and Treatment. 40(1-2). 7–13. 8 indexed citations
9.
Sakata, Shinya, Sho Saeki, Ryo Sato, et al.. (2017). Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma. Respiratory Investigation. 55(6). 372–375. 5 indexed citations
10.
Nakahara, Yoshiro, Tomoya Fukui, Ken Katono, et al.. (2017). Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature. Case Reports in Oncology. 10(1). 333–338. 9 indexed citations
11.
Kasajima, Masashi, Satoshi Igawa, Sakiko Otani, et al.. (2017). Correlation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer. Oncology Letters. 13(3). 1719–1724. 4 indexed citations
12.
Nakahara, Yoshiro, et al.. (2017). Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung disease. Molecular and Clinical Oncology. 7(4). 604–608. 14 indexed citations
13.
Nakahara, Yoshiro, Jiichiro Sasaki, Tomoya Fukui, et al.. (2017). The role of prophylactic cranial irradiation for patients with small-cell lung cancer. Japanese Journal of Clinical Oncology. 48(1). 26–30. 12 indexed citations
14.
Yoneyama, Hiroshi, et al.. (2017). Risk factors for neutropenia during gemcitabine and nanoparticle albumin-bound paclitaxel combination chemotherapy. Annals of Oncology. 28. ix106–ix106. 2 indexed citations
15.
Hotta, Katsuyuki, Jiichiro Sasaki, Sho Saeki, et al.. (2015). Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non–Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol. Clinical Lung Cancer. 17(1). 75–79. 11 indexed citations
16.
Igawa, Satoshi, Nobuyuki Yanagisawa, Yasuhiro Hiyoshi, et al.. (2015). Successful chemotherapy with carboplatin and nab-paclitaxel for thymic large cell neuroendocrine carcinoma: A case report. Oncology Letters. 10(6). 3519–3522. 8 indexed citations
17.
Igawa, Satoshi, Jiichiro Sasaki, Sakiko Otani, et al.. (2013). Evaluation of Amrubicin as a Third or Later Line of Chemotherapy for Advanced Non-Small Cell Lung Cancer. Chemotherapy. 59(2). 99–105. 5 indexed citations
18.
19.
Ikeda, Koei, Hiroaki Nomori, Takeshi Mori, Jiichiro Sasaki, & Toshiaki Kobayashi. (2008). Novel Germline Mutation: EGFR V843I in Patient With Multiple Lung Adenocarcinomas and Family Members With Lung Cancer. The Annals of Thoracic Surgery. 85(4). 1430–1432. 49 indexed citations
20.
Fujimoto, Hisao, Yukio Ando, Yoshiya Tanaka, et al.. (1997). Nitric Oxide Synthase Activity in Human Lung Cancer. Japanese Journal of Cancer Research. 88(12). 1190–1198. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koichi Kurishima Breakdown of academic impact, for papers by Fumihiko Hirai Breakdown of academic impact, for papers by Michela Roberto Breakdown of academic impact, for papers by Fumiyoshi Ohyanagi Breakdown of academic impact, for papers by Sarita Dubey Breakdown of academic impact, for papers by Kazuhiko Shibata Breakdown of academic impact, for papers by Zhihuang Hu Breakdown of academic impact, for papers by Yuichiro Takeda Breakdown of academic impact, for papers by Angelica Petrillo Breakdown of academic impact, for papers by Motoharu Hamatake
Rankless by CCL
2026